Behavioral Health

Autism spectrum disorder in adults: recognition

Clinical Overview and When to Suspect Adult ASD

— Milder presentations (formerly "Asperger") were historically missed

— Women, racial/ethnic minorities, and individuals with normal/high IQ are under-diagnosed

— "Camouflaging" or masking delays detection until adolescence or adulthood

— Lifelong difficulty with reciprocal conversation, friendships, or workplace social norms

— Sensory hypersensitivity (lights, textures, sounds) or hyposensitivity

— Intense circumscribed interests, rigid routines, distress with change

— History of repeated mental health diagnoses (anxiety, depression, OCD, eating disorder, ADHD) without full response to standard treatment

— Family history of ASD, learning disability, or "eccentric" relatives

— Self-referral after a child or sibling is diagnosed (very common Step 3 stem trigger)

Board pearl: A 28-year-old woman presents with "treatment-resistant anxiety," sensory overload at work, and difficulty with small talk; her 4-year-old nephew was recently diagnosed with ASD — think adult ASD, not just generalized anxiety.

Step 3 management: Recognition in primary care should prompt validated screening (AQ-10) and referral to a clinician experienced in adult ASD diagnosis rather than reflexive psychotropic escalation.

Autism spectrum disorder (ASD) is a neurodevelopmental condition defined by persistent deficits in social communication/interaction plus restricted, repetitive patterns of behavior, interests, or activities, with onset in the early developmental period (DSM-5-TR).

Adult recognition is increasingly common because:

When to suspect ASD in an adult primary care or psychiatric visit:

Epidemiology: prevalence ~2.8% in US children (CDC); adult prevalence presumed similar but largely undiagnosed. Male:female diagnostic ratio ~3–4:1, but true ratio likely closer to 2–3:1 due to female under-recognition.

Comorbidity is the rule, not the exception: anxiety disorders (~40%), depression (~35%), ADHD (30–50%), OCD, tic disorders, epilepsy, GI symptoms, and sleep disturbance.

Presentation Patterns and Key History

— Difficulty reading nonverbal cues (eye contact, facial expression, body language)

— Literal interpretation, trouble with sarcasm, idioms, or implied meaning

— One-sided conversations centered on areas of interest

— Limited or atypical reciprocity in friendships/romantic relationships

— Reports of being told they are "blunt," "rude," or "robotic" despite kind intent

— Insistence on sameness (same route, foods, schedule); distress with minor change

— Highly focused interests (often encyclopedic knowledge of niche topics)

— Stereotyped movements (rocking, hand-flapping) — may be suppressed in public

— Sensory: aversion to fluorescent light, tags on clothing, loud restaurants; or seeking deep pressure, spinning

— Delayed or atypical language milestones (or precocious vocabulary with pragmatic deficits)

— Childhood: solitary play, intense interests, school social difficulties, bullying

— Collateral history from a parent or old school records is strongly recommended

— Better superficial social mimicry ("masking"), intense interests in socially typical topics (animals, celebrities, literature)

— Internalizing comorbidity (anxiety, depression, eating disorders, self-harm)

— Often misdiagnosed first as borderline personality disorder or social anxiety

— Employment instability despite intelligence/skill, executive dysfunction, autistic burnout

— Higher rates of unemployment/underemployment and social isolation

Key distinction: Social anxiety patients want social interaction but fear judgment; ASD patients often find social interaction inherently confusing or fatiguing regardless of anxiety level.

Board pearl: Lifelong, pervasive, cross-situational social-communication difficulty present since early childhood is required — adult-onset social withdrawal is not ASD.

Core social-communication features in adults:

Restricted/repetitive behaviors:

Developmental history is the diagnostic backbone:

Female-pattern presentation (high-yield):

Functional impact:

Physical Exam Findings and Mental Status Assessment

— Appearance/behavior: atypical posture, limited gesture, may avoid eye contact or stare intensely

— Speech: unusual prosody (monotone, sing-song, overly formal "little professor"), pedantic vocabulary, perseveration on preferred topics

— Affect: may appear flat, incongruent, or restricted; not the same as depressive blunting

— Thought process: typically linear/concrete; tangential around special interests

— Thought content: intense preoccupations, not delusional (insight into others' lack of interest)

— Cognition: intact orientation; executive function and theory-of-mind tasks often impaired

— Insight: variable; many adults have strong insight after self-discovery

— Dysmorphic features → fragile X, tuberous sclerosis, 22q11.2 deletion

— Skin: hypopigmented macules, shagreen patches, facial angiofibromas (tuberous sclerosis); café-au-lait spots (NF1)

— Macrocephaly (PTEN-related), microcephaly

— Neurologic: tics, stereotypies, gait abnormalities, hypotonia

— Hearing assessment — always evaluate hearing if communication concerns

— Patient may flinch at exam-room lights, request quiet, wear sunglasses/earplugs

Key distinction: Flat affect of ASD reflects expressive difference, not anhedonia — patients may describe rich internal emotional experience they cannot externally signal. This separates ASD from depression and schizophrenia negative symptoms.

Step 3 management: Always perform a focused neurocutaneous exam in newly recognized adult ASD; identifying tuberous sclerosis or NF1 changes surveillance and family counseling.

ASD has no pathognomonic physical exam findings; the diagnosis is clinical, based on observation and history. However, the exam serves to identify comorbid/syndromic conditions and rule out mimics.

Mental status exam observations suggestive of ASD:

General physical exam — screen for syndromic/comorbid findings:

Sensory profile observation:

Diagnostic Workup — Initial Evaluation and Screening Tools

— Confirm diagnosis with structured assessment

— Identify comorbid psychiatric/medical conditions

— Exclude mimics (hearing loss, schizophrenia spectrum, severe anxiety, personality disorder)

— AQ-10 (Autism Spectrum Quotient–10): brief 10-item screen; ≥6 prompts specialist referral

— AQ-50: longer self-report

— RAADS-R (Ritvo Autism Asperger Diagnostic Scale–Revised): self-report, useful in adults

— EQ (Empathy Quotient) as adjunct

— TSH (rule out hypothyroidism mimicking cognitive slowing/withdrawal)

— CBC, CMP, B12, vitamin D (commonly low in restrictive eaters)

— Pregnancy test before prescribing psychotropics in reproductive-age women

— Lead level if pica or environmental exposure

— Chromosomal microarray (CMA) and Fragile X (FMR1) testing are first-tier if ASD is confirmed and patient/family desires etiology, recurrence risk counseling, or has intellectual disability, dysmorphism, seizures, or family history

— Whole-exome sequencing if CMA negative and syndromic features present

Step 3 management: A primary care physician's role is to screen (AQ-10), evaluate comorbidities, and refer to a psychiatrist/psychologist or specialty ASD clinic for formal DSM-5-TR diagnostic evaluation — not to make the diagnosis unilaterally in a single visit.

Board pearl: Routine MRI brain is not indicated for ASD evaluation absent focal neuro findings, regression, or seizures.

ASD diagnosis is clinical, based on DSM-5-TR criteria; there is no laboratory or imaging test that diagnoses ASD.

Initial workup goals:

Validated adult screening instruments (used in primary care/psychiatry):

Baseline labs are not required to diagnose ASD but consider:

Hearing and vision screening — essential, especially with communication or sensory complaints.

Genetic testing in adults:

EEG only if seizures suspected; routine EEG is not indicated.

Diagnostic Workup — Confirmatory Structured Assessment

— DSM-5-TR criteria application

— Structured interview + direct observation + collateral developmental history

— ADOS-2 (Autism Diagnostic Observation Schedule, 2nd ed.) Module 4 — semi-structured observation for verbally fluent adolescents/adults; considered gold standard for direct observation

— ADI-R (Autism Diagnostic Interview–Revised) — caregiver/parent interview about developmental history; requires informant who knew patient in childhood

— MIGDAS-2 — alternative observational tool, less stigmatizing for adults

— A. Persistent deficits in social communication/interaction across multiple contexts (social-emotional reciprocity; nonverbal communication; relationships) — all 3 required

— B. Restricted, repetitive patterns — ≥2 of 4: stereotyped behaviors, insistence on sameness, restricted interests, sensory abnormalities

— C. Symptoms present in early developmental period (may be masked later)

— D. Cause clinically significant impairment

— E. Not better explained by intellectual disability alone

— Screen for ADHD (often co-occurring; ASD + ADHD now a permitted dual diagnosis since DSM-5)

— Anxiety disorders, depression, OCD, PTSD, eating disorders

— Sleep disorders (insomnia, OSA)

— Substance use (alcohol, cannabis often used to manage social distress)

— Suicide risk — markedly elevated in adult ASD, especially women

Key distinction: Severity level in ASD (1, 2, or 3) reflects current support needs, not lifelong prognosis — levels can shift with environment, supports, and life stage.

Board pearl: Collateral developmental history from a parent or childhood records is the single most powerful diagnostic element in adult ASD evaluation.

Gold-standard diagnostic assessment is conducted by a trained clinician (psychiatrist, psychologist, developmental specialist) and integrates:

Validated diagnostic instruments for adults:

DSM-5-TR criteria (must meet all of A–E):

Specifiers: with/without intellectual impairment, language impairment, associated medical/genetic condition, catatonia; severity levels 1–3 based on support needs.

Comorbidity workup at diagnosis:

Risk Stratification and First-Line Management Logic

— 1. Safety screen: suicidality (rate 3–7× general population), self-harm, victimization, exploitation

— 2. Comorbid psychiatric disorder treatment: anxiety, depression, OCD, ADHD

— 3. Functional supports: vocational, educational, social skills, independent living

— 4. Caregiver/family education and support

— 5. Address sensory environment (workplace/home accommodations)

— Level 1 ("requiring support"): can function with minimal scaffolding; benefits from CBT, social skills training, vocational coaching

— Level 2 ("substantial support"): structured day programs, supported employment, more intensive caregiver involvement

— Level 3 ("very substantial support"): often co-occurring intellectual disability; requires comprehensive services, guardianship considerations

— Cognitive behavioral therapy (CBT) adapted for ASD — strongest evidence for comorbid anxiety/depression

— Social skills group training

— Vocational rehabilitation and supported employment (e.g., Project SEARCH model)

— Occupational therapy for sensory integration and ADLs

— Speech-language therapy for pragmatic communication

— Identify a medical home with longitudinal relationship

— Connect to state developmental disability services (eligibility usually requires ID; ASD alone varies by state)

— Autism Speaks/ASAN patient resources, neurodiversity-affirming framing

Step 3 management: First step after confirming adult ASD diagnosis is not to start medication — it is to identify and treat the most impairing comorbid condition (often anxiety or depression) with evidence-based therapy ± SSRI.

Board pearl: Behavioral and psychosocial interventions are first-line; medications target specific symptoms or comorbidities, never "autism" as a whole.

Once diagnosed, frame management around functional needs, not symptom suppression. ASD itself is not treated pharmacologically — comorbidities and target symptoms are.

Initial management priorities (in order):

Stratify support needs using DSM-5-TR levels:

Non-pharmacologic interventions (first-line for core features):

Care coordination:

Pharmacotherapy — Targeted Symptom and Comorbidity Management

— SSRIs first-line: sertraline, escitalopram, fluoxetine

— Start low, go slow — ASD patients often have heightened sensitivity to side effects and paradoxical activation/agitation

— Typical starting dose 25–50% of usual; titrate every 2–4 weeks

— Monitor for behavioral activation, akathisia, increased irritability

— SSRIs at higher doses (similar to OCD dosing) if interfering with function

— Evidence weaker than in primary OCD; behavioral therapy (ERP adapted) preferred

— Stimulants (methylphenidate, amphetamines) effective but with lower response rate and more side effects than in non-ASD ADHD

— Atomoxetine or alpha-2 agonists (guanfacine ER, clonidine) — useful alternatives, especially with anxiety or tics

— Risperidone and aripiprazole — only FDA-approved agents for irritability in ASD (approved in pediatric ASD; off-label in adults)

— Monitor weight, lipids, glucose, prolactin, EPS, tardive dyskinesia

— Avoid as first-line for anxiety or non-specific behavioral issues

— Sleep hygiene first; melatonin has best evidence (1–6 mg, 30 min before bed)

— Avoid chronic benzodiazepines, diphenhydramine

— Presents as marked motor slowing, mutism, withdrawal, often misread as "worsening autism"

— Treat with lorazepam challenge; ECT if refractory

Board pearl: A patient with ASD on multiple psychotropics who develops new immobility, posturing, mutism, and refusal to eat — think catatonia, give IM lorazepam 1–2 mg and reassess.

Step 3 management: Document target symptom, baseline severity, response measure, and re-evaluation date for every psychotropic — "measurement-based care" is expected on Step 3 stems.

No FDA-approved medication treats core ASD social-communication deficits in adults. Pharmacotherapy targets specific symptoms or comorbid disorders.

Anxiety/depression (most common indication):

Obsessive-compulsive symptoms / repetitive behaviors:

ADHD (co-occurring in 30–50%):

Irritability/aggression/severe self-injury (when behavioral approaches insufficient):

Sleep disturbance:

Catatonia in ASD (5–10% of adolescents/adults — under-recognized):

Avoid: routine antipsychotic use for anxiety; benzodiazepines (disinhibition); polypharmacy creep.

Non-Pharmacologic and Systems-Based Interventions

— CBT adapted for ASD: concrete language, visual aids, longer sessions, written summaries — strong evidence for anxiety, depression, OCD

— Social skills training (SST): group-based (e.g., PEERS for Young Adults program) — improves social knowledge; real-world generalization variable

— Mindfulness-based stress reduction: emerging evidence for emotion regulation and burnout

— Dialectical behavior therapy (DBT) skills: useful when emotion dysregulation prominent (especially women previously misdiagnosed with BPD)

— Sensory integration strategies (noise-canceling headphones, sunglasses, weighted blankets, fidgets)

— Executive function coaching (planners, task analysis, environmental structuring)

— ADL/IADL training: meal prep, hygiene, money management, transportation

— Pragmatic language therapy, conversation skills

— AAC (augmentative/alternative communication) for nonverbal/minimally verbal adults

— Vocational Rehabilitation services (state agencies) — eligibility based on disability and employment goal

— Supported/customized employment, job coaching, workplace accommodations under ADA

— Disclosure decisions: balance accommodation access with stigma — patient-driven

— Range from independent apartments → supported living → group homes

— Medicaid HCBS (Home and Community-Based Services) waivers in many states

— Psychoeducation, caregiver support groups, respite services

— Sibling and partner counseling (relationship dynamics)

— Connect to neurodiversity-affirming communities; many adults benefit from peer mentorship

CCS pearl: For an adult ASD patient with new-onset depression, order CBT referral, sertraline 25 mg daily, vocational rehab referral, PHQ-9 at 4 weeks, and suicide risk assessment before advancing the clock.

Key distinction: Applied behavior analysis (ABA) is controversial in adults and largely a pediatric framework; adult care emphasizes CBT, skills training, and accommodation.

Evidence-based psychosocial treatments form the backbone of adult ASD care:

Occupational therapy:

Speech-language pathology:

Vocational and educational supports:

Housing and independent living:

Family/caregiver interventions:

Peer support and self-advocacy:

Special Populations — Elderly and Renal/Hepatic Impairment

— Lifelong eccentricity often attributed to "personality" or "schizoid traits"

— Late-life social withdrawal may be misattributed to depression or early dementia

— Differentiate: ASD features are lifelong and stable; dementia features are acquired and progressive with cognitive decline

— Some evidence of accelerated executive function decline; data still emerging

— Higher rates of cardiovascular disease, diabetes, hypertension — partly from psychotropic burden, sedentary behavior, and healthcare avoidance

— Screen aggressively for undertreated chronic disease

— Older ASD adults often accumulate antipsychotics, benzodiazepines, anticholinergics from decades of behavioral management

— Beers criteria and STOPP/START apply — avoid anticholinergics (worsen cognition), long-acting benzodiazepines (falls, delirium)

— Antipsychotics in elderly carry boxed warning for increased mortality in dementia — reassess indication

— SSRIs: generally safe; paroxetine, citalopram require dose reduction in severe CKD

— Atomoxetine: no renal adjustment but metabolized hepatically

— Risperidone, aripiprazole: start low in renal impairment

— Lithium (if used for mood/aggression): contraindicated/cautious in CKD; narrow therapeutic index

— Avoid duloxetine in significant hepatic disease

— Reduce doses of sertraline, escitalopram in hepatic impairment

— Use methylphenidate cautiously (hepatic metabolism)

Board pearl: A 72-year-old "lifelong loner" with intense interest in train schedules, sensory aversion, and recent depression after wife's death — consider previously undiagnosed adult ASD, not new schizoid personality disorder or dementia.

Step 3 management: Annually review and deprescribe in older ASD adults — target anticholinergics, benzodiazepines, and antipsychotics first.

Older adults with ASD are an emerging clinical population — many were never diagnosed because adult ASD was poorly recognized before the 1990s.

Recognition issues in older adults:

Cognitive aging in ASD:

Polypharmacy and deprescribing:

Renal impairment dosing:

Hepatic impairment:

QTc considerations: citalopram >20 mg in older adults contraindicated; check ECG before starting/changing dose-dependent QT-prolonging drugs.

Special Populations — Women, Pregnancy, and Cultural Considerations

— Diagnostic instruments developed largely on male samples; female phenotype includes more masking, internalizing symptoms, socially typical special interests

— Often first diagnosed with anxiety, depression, eating disorders, OCD, borderline personality disorder, or complex PTSD before ASD recognized

— Higher rates of sexual victimization and exploitation — screen routinely

— Catamenial worsening of sensory and emotional symptoms

— Sensory aversion may complicate pelvic exams, contraception choices (IUD insertion), and obstetric care — offer accommodations (extended appointments, written materials, trauma-informed approach)

— Discuss contraception proactively; account for psychotropic teratogenicity

— SSRIs: generally continue if indicated; paroxetine associated with cardiac defects — avoid first trimester

— Sertraline preferred SSRI in pregnancy and lactation

— Valproate strictly avoided (teratogenicity, neurodevelopmental harm) — particularly relevant given off-label use for irritability

— Atypical antipsychotics: risk-benefit; risperidone/aripiprazole acceptable if needed; monitor neonatal adaptation

— Stimulants: weigh risks; methylphenidate has more reassuring data than amphetamines

— Folate supplementation; manage sensory needs of L&D environment

— Loss of pediatric services cliff at age 18/22 — leading cause of decompensation

— Plan transition early: adult PCP, adult psychiatrist, vocational services, insurance (Medicaid redetermination, SSI/SSDI)

— Black, Hispanic, and Asian American adults diagnosed later and less often

— LGBTQ+ identification is overrepresented in ASD populations — provide affirming care

— Language and immigration status barriers reduce access

Key distinction: A woman with chronic emptiness, identity disturbance, sensory overload, and exhaustive masking who "shuts down" rather than acts out — consider ASD before defaulting to borderline personality disorder.

Step 3 management: Begin structured transition planning at age 14–16 for adolescents with ASD; on Step 3, the right answer is often "coordinate adult care before pediatric discharge."

Women with ASD — historically under-diagnosed:

Reproductive health:

Pregnancy considerations:

Transition-age youth (18–25):

Cultural/ethnic disparities:

Complications and Adverse Outcomes

— Suicide: lifetime suicidal ideation 30–50%; attempts ~20%; completed suicide rates 3–9× general population, highest in women and those without intellectual disability

— Autistic burnout: chronic exhaustion, loss of skills, increased sensory sensitivity from prolonged masking and demand overload — often misdiagnosed as depression

— Catatonia: 5–10% prevalence in ASD adolescents/adults; under-recognized

— Severe anxiety, depression, OCD, PTSD

— Substance use disorders — increased risk, especially alcohol and cannabis

— Cardiometabolic: higher rates of obesity, T2DM, hypertension, dyslipidemia — partly from antipsychotic exposure and reduced physical activity

— GI: chronic constipation, GERD, food selectivity → nutrient deficiencies (iron, B12, vitamin D, fiber)

— Epilepsy: lifetime prevalence ~20–30%, bimodal peaks in early childhood and adolescence

— Sleep disorders: insomnia, delayed sleep phase, OSA

— Sensory injuries: unrecognized fractures/illnesses due to atypical pain reporting

— Unemployment/underemployment (~50–85% of adults with ASD)

— Social isolation, loneliness

— Victimization — physical, sexual, financial; screen routinely

— Homelessness risk, justice-system involvement (often as victims; sometimes for misinterpreted behavior)

— Diagnostic overshadowing: new medical symptoms attributed to ASD rather than investigated → missed appendicitis, MI, malignancy

— Polypharmacy, metabolic syndrome from antipsychotics, tardive dyskinesia

— Restraint and seclusion trauma in ED/inpatient settings

Board pearl: An ASD adult brought to ED for "behavioral outburst" who is then found to have urinary retention, dental abscess, or fecal impaction — rule out occult medical pain before assuming psychiatric cause.

Key distinction: Autistic burnout ≠ depression — burnout responds to demand reduction and accommodation, not antidepressants alone, though the two often coexist.

Psychiatric complications:

Medical complications:

Social and functional complications:

Iatrogenic complications:

When to Escalate Care — Crisis, Consult, and Inpatient Triage

— Active suicidal ideation with plan/intent or recent attempt

— Severe self-injurious behavior with medical compromise

— Aggression endangering self/others not manageable in outpatient setting

— New catatonia (mutism, immobility, posturing, refusal of food/fluids)

— Acute psychotic symptoms (consider comorbid schizophrenia or substance-induced)

— Acute medical decompensation masked as behavioral change

— Sensory-friendly environment: dim lights, quiet room, minimize alarms, limit personnel

— Communication: ask preferred mode (written, AAC), use concrete literal language, allow extra processing time

— Involve caregivers/familiar supports early

— Avoid restraint when possible; use behavioral de-escalation, predictable routines

— Bring sensory items from home (headphones, weighted blanket, comfort objects)

— Diagnostic uncertainty in newly suspected adult ASD

— Treatment-resistant comorbid psychiatric illness

— Suspected catatonia

— Behavioral escalation requiring antipsychotic initiation

— Need for capacity assessment, guardianship evaluation

— Developmental disability specialist or autism specialty clinic

— Genetics (CMA, Fragile X, syndromic features)

— Neurology for seizures or movement disorders

— Sleep medicine for refractory insomnia/OSA

— Vocational rehabilitation, state developmental disability agency

— Standard civil commitment criteria apply (danger to self/others, grave disability)

— Consider capacity carefully — ASD does not equal lack of capacity

CCS pearl: For an ASD adult in ED with agitation, first orders are: vital signs, glucose, focused medical exam for occult pain source (dental, abdominal, urinary, ear), sensory accommodation, and collateral history — before PRN antipsychotics.

Step 3 management: Escalation should preserve continuity — identify the patient's outpatient team and communicate before discharge to prevent decompensation.

Emergent escalation indications:

ED/inpatient considerations specific to ASD:

Psychiatric consult/referral triggers:

Subspecialty/system referrals:

Voluntary vs involuntary hospitalization:

Key Differentials — Other Psychiatric Conditions

— Shared: social discomfort, avoidance

— Distinction: SAD patients desire social connection and have intact pragmatic skills; fear is judgment-based; onset often adolescence; responds well to CBT/SSRIs alone

— ASD: social difficulty is skill-based and lifelong; anxiety often secondary to repeated misunderstandings

— Shared: social withdrawal, odd speech, restricted affect

— Distinction: schizophrenia has positive symptoms (delusions, hallucinations, formal thought disorder) and typically later onset (late teens–20s); ASD is lifelong from early childhood without psychosis

— Schizotypal: magical thinking, ideas of reference, paranoid ideation — not characteristic of ASD

— Shared: social inhibition, feelings of inadequacy

— Distinction: avoidant PD driven by fear of criticism, not deficit in social-pragmatic skills; emerges in adolescence, not early childhood

— Shared: preference for solitary activities, restricted affect

— Distinction: schizoid lacks desire for relationships; ASD adults often desire connection but struggle to achieve it; ASD has developmental onset and restricted/repetitive features

— Shared: repetitive behaviors, insistence on sameness

— Distinction: OCD compulsions are ego-dystonic and driven by intrusive obsessions/anxiety; ASD repetitive behaviors are often ego-syntonic and pleasurable or self-regulatory

— Can co-occur; treat each

— Shared: executive dysfunction, sensory issues, social difficulty

— Distinction: ADHD social problems stem from inattention/impulsivity, not pragmatic-language deficits

— Both can co-exist (DSM-5 allows dual diagnosis)

— Shared: emotional dysregulation, identity disturbance, relationship difficulty (especially in women)

— Distinction: BPD features fear of abandonment, idealization-devaluation, impulsivity, self-harm patterns; ASD lacks the interpersonal manipulation dynamic and has developmental onset

Key distinction: The strongest discriminator across these differentials is developmental history — ASD features are present in early childhood; most personality/anxiety/psychotic disorders emerge in adolescence or later.

Social anxiety disorder (SAD):

Schizophrenia spectrum / schizotypal personality disorder:

Avoidant personality disorder:

Schizoid personality disorder:

OCD:

ADHD:

Borderline personality disorder:

Key Differentials — Medical, Neurologic, and Syndromic Mimics

— Global cognitive impairment with proportionate social skills; ASD has disproportionate social-communication deficits relative to overall cognition

— Frequently co-occur (~30% of ASD has ID)

— Can mimic social-communication deficits; always audiology screen before diagnosing ASD

— Communication deficits without restricted/repetitive behaviors → DSM-5 social (pragmatic) communication disorder rather than ASD

— Social engagement deficits from environmental deprivation; differentiate via history; improves with stable caregiving

— Social and executive deficits with characteristic facies, growth restriction, prenatal alcohol exposure history

— Fragile X syndrome: long face, large ears, macroorchidism, intellectual disability — most common inherited cause of ID/ASD

— Rett syndrome: girls with normal early development → regression, stereotyped hand movements (hand-wringing), respiratory irregularity; MECP2 mutation

— Tuberous sclerosis complex: ash-leaf spots, shagreen patches, facial angiofibromas, seizures, cortical tubers; TSC1/TSC2

— 22q11.2 deletion syndrome: cardiac defects, palatal anomalies, hypocalcemia, learning disability, psychosis risk

— Phelan-McDermid (22q13): hypotonia, severe ID, ASD features

— PTEN hamartoma syndrome: macrocephaly, hamartomas, cancer risk

— Temporal lobe epilepsy can mimic social withdrawal/odd behaviors

— Frontotemporal dementia (behavioral variant) — adult-onset social/personality change, not lifelong — key distinguishing feature

— Anti-NMDA receptor encephalitis — subacute psychosis, movement disorders, autonomic instability

— Untreated hypothyroidism, B12 deficiency, neurosyphilis, HIV-associated cognitive disorder — exclude in atypical adult presentations

Board pearl: Acquired/adult-onset social withdrawal, personality change, or "autistic-like" behavior in a previously typical adult is bvFTD or encephalitis until proven otherwise — order MRI brain, consider LP, autoimmune panel.

Key distinction: ASD = lifelong developmental; FTD = acquired progressive.

Intellectual disability (ID) without ASD:

Hearing impairment:

Language disorders (developmental language disorder, pragmatic communication disorder):

Reactive attachment disorder / severe childhood neglect:

Fetal alcohol spectrum disorders (FASD):

Genetic syndromes presenting with ASD features:

Acquired conditions:

Long-Term Plan and Health Maintenance

— Designated PCP experienced with ASD, ideally same provider over time

— Psychiatrist for comorbidity management

— Therapist (CBT-adapted) for ongoing skills and crisis support

— Care coordinator or case manager for complex needs

— Specialist referrals as indicated (neurology, sleep, GI, genetics)

— Cancer screening per USPSTF: cervical (21–65), colorectal (45–75), breast (40/50–74), lung CT if eligible — accommodation often required for cervical exams

— Cardiovascular: BP at every visit, lipid screening, ASCVD risk calculation; aggressive metabolic monitoring if on antipsychotics (weight, waist, BP, fasting glucose, lipids — baseline, 12 weeks, then annually per ADA/APA monitoring protocol)

— Diabetes: screen per USPSTF (35–70 with overweight); more frequent if antipsychotics

— Immunizations per CDC adult schedule

— Dental care — often deferred due to sensory aversion; arrange sensory-accommodating dentistry

— Vision and hearing screening

— Bone health: vitamin D, calcium, especially with restricted diets or antiseizure drugs

— Physical activity prescription (predictable, structured exercise)

— Nutrition counseling for food selectivity → consider RD referral

— Sleep hygiene reinforcement

— Sexual health education (often skipped in adolescence)

— Advance directives, supported decision-making, guardianship considerations

— SSI/SSDI eligibility, ABLE accounts, special needs trusts

— ADA workplace accommodations

Step 3 management: For an adult with ASD on risperidone, schedule fasting lipids, glucose/HbA1c, weight, and BP at baseline, 3 months, and annually, plus AIMS (abnormal involuntary movement scale) every 6–12 months.

Board pearl: Adults with ASD have excess all-cause mortality largely driven by suicide, epilepsy, and cardiovascular disease — preventive care is life-saving.

Adult ASD care is longitudinal and multidisciplinary; no "discharge" — patients need a stable medical home.

Components of long-term plan:

Preventive health (often neglected in ASD adults):

Lifestyle and skills:

Legal/financial planning:

Follow-Up, Monitoring, and Counseling Cadence

— Stable, no active psychotropic changes: PCP every 6–12 months; psychiatry every 3–6 months

— Active psychotropic titration: every 2–4 weeks until stable, then space out

— High-risk periods (life transitions, illness, loss, new job): increase frequency

— SSRI: PHQ-9 and GAD-7 at baseline, 4 weeks, 8 weeks, 12 weeks; assess activation, sleep, sexual side effects, suicidality (especially under 25)

— Stimulants: BP, HR, weight at each visit; sleep, appetite, tics, mood

— Atypical antipsychotics: weight/BMI, waist, BP, fasting glucose/HbA1c, lipids (baseline, 12 wk, then yearly); AIMS every 6–12 months; prolactin if symptomatic

— Mood stabilizers: drug-specific (lithium levels + renal/thyroid; valproate level + LFTs + CBC)

— Suicide risk screen (use direct, concrete language — "Are you thinking about killing yourself?")

— Sleep, appetite, activity, social engagement

— Substance use (especially alcohol, cannabis)

— Sensory environment, accommodation needs

— Caregiver burden, relationship status

— PHQ-9, GAD-7, Y-BOCS for comorbidities

— Functional measures: employment status, independent living skills, social engagement

— Patient-defined goals (quality of life, valued activities)

— Written summaries after each visit (literal, concrete, with action items)

— Patient portal messaging often preferred over phone calls

— Avoid surprise schedule changes — communicate transitions early

— Always with patient consent (HIPAA); identify trusted contact early

— Develop crisis plan including triggers, early warning signs, preferred interventions, and emergency contacts

Step 3 management: Document measurement-based care — quantitative scales at defined intervals — Step 3 vignettes frequently reward this over "subjective improvement."

CCS pearl: Always advance the clock with explicit f/u in 4 weeks with PHQ-9 and GAD-7 after starting an SSRI in an ASD adult.

Visit cadence:

Monitoring parameters by intervention:

Counseling at every visit:

Outcome measures to follow:

Care transitions and safety:

When to involve family/supports:

Ethical, Legal, and Patient Safety Considerations

— ASD diagnosis ≠ lack of decision-making capacity. Assess capacity decision-specifically: understanding, appreciation, reasoning, communication of choice

— Use plain language, written materials, visual aids; allow extra processing time; involve trusted supporters if patient wishes

— Supported decision-making is the preferred modern framework over guardianship when feasible

— Full guardianship/conservatorship reserved for cases where less restrictive options fail

— Adults receiving a new ASD diagnosis often experience grief, relief, and identity reorganization — counsel sensitively

— Discuss disclosure to employers, family — patient-driven decision; respect autonomy

— ASD is a recognized disability under the Americans with Disabilities Act (ADA)

— Reasonable accommodations: written instructions, noise-canceling headphones, flexible schedule, quiet workspace

— Disclosure to employer required only if accommodation requested

— Adults with ASD are at high risk of abuse, neglect, financial exploitation

— Adult Protective Services (APS) reporting required in most states when vulnerable adult abuse is suspected — clinician duty regardless of patient preference if patient lacks capacity to self-protect

— Default is patient-directed disclosure, even when caregivers are heavily involved

— Obtain written authorization; revisit periodically

— ASD adults may misinterpret commands, fail to make eye contact, or have unusual movements — at risk of escalation, wrongful arrest

— Counsel about identification cards (autism alert), advance contacts with local crisis intervention teams

— Pediatric → adult transition is a major decompensation risk; ensure adult PCP, psychiatrist, and case manager are in place before pediatric discharge; medication reconciliation, written care plan, and warm handoff prevent gaps

— Avoid coercive interventions; neurodiversity-affirming care respects autistic identity as part of the person, not pathology to eliminate

Step 3 management: When a 19-year-old with ASD ages out of pediatrics, the correct answer is structured warm handoff to an adult team with explicit medication reconciliation and written care plan, not "discharge home with PRN psychiatry referral."

Capacity and informed consent:

Diagnostic disclosure:

Workplace and ADA:

Mandatory reporting:

Confidentiality with caregivers:

Police and legal interactions:

Transition-of-care safety (Step 3 high-yield):

Research and treatment ethics:

High-Yield Associations and Rapid-Fire Clinical Facts

— Heritability ~80%; siblings of affected individuals at ~10–20× increased risk

— First-tier genetic testing in confirmed ASD with ID/syndromic features: chromosomal microarray + Fragile X (FMR1)

— Most common identifiable genetic causes: Fragile X, 15q11–13 duplication, 16p11.2 deletion/duplication, tuberous sclerosis, Rett, PTEN, SHANK3

Board pearl: Stereotyped hand-wringing + regression + female + acquired microcephaly + breathing irregularities = Rett syndrome (MECP2) — distinct from primary ASD.

Key distinction: Vaccines do not cause autism — this is settled; on Step 3, the correct answer is always to continue routine vaccination and provide evidence-based counseling.

Genetics:

Sex ratio: ~3–4:1 male:female diagnosed; true ratio likely ~2–3:1

Epilepsy: ~20–30% lifetime; bimodal peaks early childhood and adolescence

Sleep problems: 50–80% of ASD adults

ADHD comorbidity: 30–50%; anxiety 40%; depression 35%; OCD 15–30%

Suicide: 3–9× general population; highest risk in women and those without ID

Catatonia: 5–10% of ASD adolescents/adults — lorazepam-responsive

Antipsychotic FDA approvals for irritability in ASD: risperidone (children 5–16) and aripiprazole (children 6–17); off-label in adults

MMR vaccine and autism: no causal link — multiple large studies refute it; continue routine immunizations

Neurodiversity framework: ASD viewed as a difference requiring accommodation, not solely a disorder requiring cure

Employment: ~50–85% unemployed/underemployed; supported employment programs improve outcomes

Life expectancy: reduced by ~16 years on average vs general population (Hirvikoski et al.); driven by suicide, epilepsy, cardiovascular disease

AQ-10 ≥6 triggers specialist referral

DSM-5-TR criteria: social-communication (all 3 of A) + restricted/repetitive (≥2 of 4 in B) + early developmental onset + impairment + not better explained by ID

Severity levels: 1 (requires support), 2 (substantial), 3 (very substantial)

Top medical comorbidities to screen: epilepsy, GI (constipation/GERD), obesity, T2DM, OSA, dental disease

Board Question Stem Patterns

— 25–35 yo woman, multiple SSRI trials with partial response, sensory overload at work, intense interest in literature/animals, exhausted by social masking, niece recently diagnosed with ASD → screen with AQ-10, refer for adult ASD diagnostic evaluation

— Lifelong solitary, intense narrow interests since childhood, monotone speech, no psychosis → adult ASD, not schizotypal (look for early childhood onset, no positive symptoms)

— 19 yo with ASD, lost services at 18, now in ED with agitation and stopped medications → establish adult psychiatry/PCP, warm handoff, medication reconciliation, vocational rehab referral

— Nonverbal adult with ASD brought in for "aggression"; vitals abnormal → search for occult medical pain (dental, urinary, GI, fracture) before sedation

— Previously verbal ASD adolescent/adult develops mutism, immobility, refusal to eat, posturing → lorazepam challenge, consider ECT if refractory

— Adult with ASD on risperidone for 1 year — best next step → fasting lipids/glucose, weight/BP, AIMS

— Parent declines MMR citing autism risk → clear evidence-based counseling that vaccines do not cause autism, motivational interviewing, continue offering at each visit

— 25 yo with ASD and mild ID needs surgery; parents request decision — best step → assess decision-specific capacity, supported decision-making first, guardianship only if necessary

— ASD adult agitated in busy ED → quiet room, dim lights, familiar caregiver, written communication, avoid restraints

— Starting sertraline → start low (25 mg), titrate slowly, monitor for activation/akathisia/suicidality, follow up 4 weeks with PHQ-9

Step 3 management: When the stem includes "lifelong" + "early childhood" + social-communication + restricted interests/sensory issues, ASD is almost always the answer regardless of adult age at presentation.

Pattern 1 — The "treatment-resistant anxiety" woman:

Pattern 2 — The "eccentric loner" misdiagnosed with schizotypal/schizoid PD:

Pattern 3 — Pediatric-to-adult transition fail:

Pattern 4 — Diagnostic overshadowing in ED:

Pattern 5 — Catatonia in ASD:

Pattern 6 — Antipsychotic monitoring:

Pattern 7 — Vaccine refusal due to autism fear:

Pattern 8 — Capacity and consent:

Pattern 9 — Sensory ED accommodation:

Pattern 10 — New SSRI in ASD:

One-Line Recap

Adult ASD is a lifelong neurodevelopmental disorder defined by early-childhood-onset social-communication deficits plus restricted/repetitive behaviors, frequently missed in women and high-functioning adults, diagnosed clinically with DSM-5-TR criteria and structured assessment, and managed through evidence-based psychosocial interventions, targeted pharmacotherapy for comorbidities, and longitudinal multidisciplinary care.

Board pearl: On Step 3, when the stem layers lifelong social difficulty, intense narrow interests, sensory sensitivities, and a family-history clue (a child or sibling with ASD), the answer is adult ASD recognition and referral, not another round of "treatment-resistant" anxiety or depression therapy.

Recognize: lifelong social-pragmatic difficulty + restricted interests/sensory features + early developmental onset; screen with AQ-10, refer for structured assessment (ADOS-2 + ADI-R); rule out hearing loss, FTD, schizophrenia, and personality disorders by checking developmental history.

Treat what's treatable: CBT adapted for ASD is first-line for comorbid anxiety/depression; SSRIs start low, go slow; risperidone/aripiprazole only for severe irritability with metabolic monitoring; lorazepam for catatonia; non-pharmacologic supports (OT, SLP, vocational rehab, accommodations) form the backbone.

Prevent the bad outcomes: screen aggressively for suicide, occult medical illness (diagnostic overshadowing kills), cardiometabolic disease, epilepsy, and victimization; deliver USPSTF-aligned preventive care with sensory accommodation.

Systems and ethics: plan pediatric-to-adult transitions early with warm handoff; respect decision-specific capacity and supported decision-making over guardianship; reasonable accommodations under ADA; mandatory APS reporting for vulnerable adult abuse; vaccines do not cause autism — continue routine immunization.